A sensitive, simple, and rapid method for the determination of flunitrazepam and its major metabolites (7-aminoflunitrazepam, 7-acetamidoflunitrazepam, and norllunitrazepam) in serum and plasma is presented. The on-line procedure uses an immobilized, highly reusable antibody against benzodiazepines for selective extraction from serum followed by analysis by high-performance liquid chromatography with ultraviolet detection. This reliable method provides a limit of detection of 1 ng/mL serum, and results are obtained in less than 40 min.
Introduction
Selective methods for the determination of flunitrazepam and metabolites in biological fluids employ gas chromatography (1-4) and high-performance liquid chromatography (HPLC) (5-10), but both require an intensive sample pretreatment employing liquid or solid-phase extraction, often in combination with a subsequent derivatization step or a preceeding hydrolysis step.
Generally, extraction solvents or sorbents lack selectivity because they are based on nonspecific interactions between the analyte and the extraction medium. As a consequence, the cleanliness of the extracts is limited by coextracted matrix compounds, which can lead to interference and elevated background noise.
Immunoaffinity extraction techniques, in contrast, employ selective interactions between the antibody and the analyte and therefore permit a highly selective sample cleanup that results in improved sensitivity and recovery (11) (12) (13) (14) (15) (16) .
By coupling immunoaffinity extraction and HPLC, the resuiting on-line technique allows direct sample injection without a time-consuming sample pretreatment. Losses of analytes during critical off-line extraction steps such as evaporation and reconstitution are avoided. In consequence, better recoveries, sensitivities, and reproducibilities can be achieved using such on-line techniques (11) (12) (13) (14) (15) .
Flunitrazepam, a potent hypnotic drug, belongs to the 1.4-benzodiazepine class and is marketed in 64 countries. Its abuse has greatly increased in recent years, and it is therefore frequently encountered in forensic and clinical casework (10, 17, 18) . Even in the U.S., where flunitrazepam is not marketed, increasing abuse of this drug has been observed (19) . Because of its low dosage, high volume of distribution (2.5 L/kg [20] ), and extensive metabolism, only low blood concentrations of flunitrazepam and its metabolites occur after a single oral dose (10, 20) .
The majority of the methods published for the determination of flunitrazepam either do not have the required sensitivity or they do not include the major metabolites. Therefore, we developed a sensitive method for the simultaneous determination of flunitrazepam and its major metabolites by HPLC following mixed-mode solid-phase extraction in 1993 (21, 22) . In the present paper, we describe an on-line immunoaffinity HPLC procedure for the determination of flunitrazepam and its major metabolites in serum. The on-line technique applied was developed recently in our workgroup (23) . 
Experimental

Materials
Potassium dihydrogenphosphate, sodium azide, sodium chloride, and orthophosphoric acid (85%) were analytical grade. Acetonitrile and methanol were HPLC grade (Merck, Darmstadt, Germany). HPLC-grade water was prepared by a Milli-Q purification system (Millipore, Bedford, ~).
Flunitrazepam, norflunitrazepam, and 7-amino-and 7-acetamidoflunitrazepam were kindly provided by H0ffmann-La Roche (Basel, Switzerland).
Stock solutions of each reference standard were prepared in methanol at a concentration of 1 mg/mL and stored at 4~ in the dark. The methanolic working solutions contained all four standards at concentrations of 10 ng/mL and 1 ng/mL.
The polyclonal antibody, raised against benzodiazepines, was kindly provided by Boehringer Mannheim (Mannheim, Germany), and 1 mg of the antibody was immobilized on glutardialdehyde activated affinity sorbent (Boehringer Mannheim) following the manufacturer's recommended procedure (16) . The immunosorbent obtained had a capacity of 1200 ng flunitrazepam.
The mobile phase consisted of a mixture of acetonitrile/0.05M potassium phosphate buffer (pH 2.0) (36:64, v/v). The pH of the buffer was adjusted by dropwise addition of orthophosphoric acid under control of a pH meter.
Apparatus
A schematic of the HPLC on-line system is shown in Figure 1 . We used three HPLC pumps (model 2150, Pharmacia LKB, Bromma, Sweden) and a tandem switching valve (Motorventil H, Besta, Heidelberg, Germany) that included two Rheodyne model 7000 two-position six-port switching valves and a UV detector (model 2151, Pharmacia LKB). The detector was operated at a wavelength of 254 nm and a sensitivity of 0.01 AUFS. The injector (model 7125, Rheodyne, Cotati, CA) was equipped with a 2.0-mL loop, which was made by 1/16-in. stainless steel tubing with a 1-mm diameter. The mobile phase delivered by pump I (P1) was HPLC-grade water at a flow rate of 0.5 mL/min, pump 2 (P2) delivered pL of HPLC-grade water, and the mixture (1 mL) was injected into the system. 0.998
The on-line analysis of samples was 0.999 performed using the set-up shown in Figure 1 and the three sequential steps summarized in Table I . In step 1, the centrifuged and diluted serum samples were loaded into the loop and injected into the system. During the first 10 rain (tandem valve position 1), the sample was pumped through the IAC by P1 at a flow rate of 0.5 mL/min, followed by water as washing solvent. P3 delivered the mobile phase through the PC and the AC. After switching the tandem valve into position 2 (step 2), the 90% methanol was pumped at a flow rate of 0.05 mL/min through the IAC for 10 rain, allowing the quantitative desorption of the analytes. P1 was used to dilute the IAC-elution mixture in the T-piece with water to a final methanol concentration below 10% in order to trap the analytes on the PC. In step 3 (tandem valve back in position 1), the mobile phase eluted the analytes from the PC following separation on the AC and detection. The IAC was regenerated by water and prepared for the next injection. After 40 rain, the system was ready for the next analysis.
When not in use, the immunocolumn was stored in a solution of sodium azide (0.1%) and sodium chloride (0.9%) in water at room temperature. 
Calculations
The concentrations were calculated by comparing the peak heights from samples to the corresponding standards containing known amounts of flunitrazepam and the metabolites. Six standards were used to produce a standard curve for each compound. Linear regression analyses of the standard curves were done using Kaleidagraph software for the Macintosh.
The percent recoveries were calculated by injecting blank serum samples spiked with known amounts of the reference standards and comparing the peak heights with those obtained from pure standards injected into the system after connecting the injector directly with the analytical column. In this case, we used a 20-pL loop instead of the 2-mL loop.
Results and Discussion
The immobilized antibody used for immunoaffinity extraction showed high stability and reusability. In our studies, more than 100 runs were performed by the IAC, and no changes in the column's performance were observed. The highly efficient sample cleanup is shown in Figure 2 . No coextracted matrix compounds were detectable when serum was extracted by the IAC. The peaks in the front area of the chromatogram are artificial and result from switching the columns. In Figure 3 , the extract of a drug-free serum sample that was spiked with flunitrazepam and each metabolite at a concentration of 10 ng/mL is shown. The isocratic mobile phase that was developed for the separation of benzodiazepines and their metabolites in further studies (10) provided baseline separation between 7-amino-and 7-acetamidoflunitrazepam and performed complete elution of all benzodiazepines tested from the analytical column in less than 17 rnin. The high recovery of the method for the benzodiazepines investigated is documented in Table II . For each compound, the rate of recovery exceeded 88%. In Tables III and IV , the data for intra-and interday precision at therapeutic and toxic serum concentrations are summarized. Linearity was tested in the concentration range from 5 to 500 ng/mL. The coefficients of determination were at least 0.998 in all cases (Table V) . The limit of detection was estimated at a signal-to-noise ratio of 3:1, and the sensitivity was better than 1 ng/mL for each compound. In Table VI , the retention times of flunitrazepam, its major metabolites, and other drugs tested for interference at high concentrations are summarized. Figure 4 shows a typical chromatogram obtained from a routine case. After taking blood from an addict (the intake of five Rohypnol tablets was noticed on the medical examiner's report), the sample was stored at 4~ for two days prior to centrifugation and analysis. The simultaneous determination of flunitrazepam and its major metabolites in flunitrazepam-positive samples results in a typical peak pattern leading to enhanced selectivity and further pharmacological information. Under conditions of storage of the samples at 4-6~ over several days or weeks, which is often the case in forensic toxicology, this pattern can change and lead to incorrect results 
Conclusions
The simultaneous determination of flunitrazepam and its major metabolites by the analytical method described reveals two main advantages: a highly selective and sensitive antibody-mediated isolation of the analytes from serum or plasma and the avoidance of a time-intensive sample pretreatment by applying an HPLC on-line technique that allows the direct injection of the sample. The immobilized antibody showed a high reusability, and results of the single step procedure were available within 40 rain. The method has been found to be highly selective, reliable, and sensitive and very suitable for the quantitative determination of the low-dose benzodiazepine flunitrazepam. Using an autosampler, the method can be fully automated, and, if slightly modified, the method should be applicable for the determination of other benzodiazepines.
